New Launch12 Mar 2026, 02:26 pm
Zydus Lifesciences Launches AI-Powered Continuous Glucose Monitors Diasens™ and GlucoLive™
AI Summary
Zydus Lifesciences Limited, an innovation-led global life sciences company, has announced the launch of Diasens™ and GlucoLive™, next-generation Continuous Glucose Monitoring (CGM) devices. These devices combine artificial intelligence-powered insights and integrated remote care capabilities. The CGM system is designed to monitor glucose with an integrated AI layer to provide analytics and enable a closed-loop care ecosystem connecting patients, caregivers, and clinicians in real time. Zydus has partnered with Digicare Health Solutions Private Limited (TatvaCare™) to help patients gain access to its proprietary, integrated care ecosystem GoodFlip™.
Key Highlights
- Zydus Lifesciences has launched Diasens™ and GlucoLive™, next-generation Continuous Glucose Monitoring (CGM) devices.
- The CGM devices combine artificial intelligence-powered insights and integrated remote care capabilities.
- The CGM system is designed to monitor glucose with an integrated AI layer to provide analytics and enable a closed-loop care ecosystem connecting patients, caregivers, and clinicians in real time.
- Zydus has partnered with Digicare Health Solutions Private Limited (TatvaCare™) to help patients gain access to its proprietary, integrated care ecosystem GoodFlip™.
- The launch is aimed at strengthening Zydus' companion diagnostics portfolio for chronic disease management, focusing on patient-centric convenience and better quality of life.